Serial testing for tuberculosis: Can we make sense of T cell assay conversions and reversions?

PLoS Medicine

Volumn 4, Issue 6, 2007, Pages 0980-0983

  Pai, Madhukar ^a   O'Brien, Richard ^b  

^a MCGILL UNIVERSITY   (Canada)

^b FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BCG VACCINE; CFP 10 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; CFP-10 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; ESAT 6 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; ESAT-6 PROTEIN, MYCOBACTERIUM TUBERCULOSIS;

ACCURACY; CELL ASSAY; DISEASE CONTROL; DISEASE COURSE; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HUMAN; IN VITRO STUDY; INCIDENCE; MEDICAL EXAMINATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROGNOSIS; RELIABILITY; REPRODUCIBILITY; REVIEW; SENSITIZATION; T LYMPHOCYTE; TUBERCULIN TEST; TUBERCULOSIS; ADOLESCENT; ADULT; AGED; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GAMBIA; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; NOTE; PREDICTIVE VALUE; SECRETION (PROCESS); SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BCG VACCINE; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GAMBIA; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTES; TREATMENT OUTCOME; TUBERCULIN TEST; TUBERCULOSIS;

EID: 34347269232     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0040208     Document Type: Review

References (15)

1. Menzies RI (2000) Tuberculin skin testing. In: Reichman LB, Hershfield ES, editors. Tuberculosis: A comprehensive international approach. New York: Marcel Dekker. pp. 279-32 2.
2. Farhat M, Greenaway C, Pai M, Menzies D (2006) False-positive tuberculin skin tests: What is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 10: 1192-1204.
3. Menzies D (1999) Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med 159: 15-21.
4. Menzies D, Pai M, Comstock G (2007) New tests for diagnosis of latent tuberculosis infection - Areas of uncertainty and recommendations for research. Annals Int Med 146: 340-354.
5. Pai M, Riley LW, Colford JM, Jr. (2004) Interferon-gamma assays in the immunodiagnosis of tuberculosis: A systematic review. Lancet Infect Dis 4: 761-776.
6. Pai M, Dheda K, Cunningham J, Scano F, O'Brien R (2007) T-cell assays for the diagnosis of latent tuberculosis infection: Moving the research agenda forward. Lancet Infect Dis. 7: 428-438.
7. Hill PC, Brookes RH, Fox A, Jackson-Sillah D, Jeffries DJ, et al. (2007) Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. PLoS Med 4: e192. doi:10.1371/journal.pmed.0040192
8. Pai M, Joshi R, Dogra S, Mendiratta DK, Narang P, et al. (2006) Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med 174: 349-355.
9. Ewer K, Millington KA, Deeks JJ, Alvarez L, Bryant G, et al. (2006) Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med 174: 831-839.
10. Hill PC, Jeffries DJ, Brookes RH, Fox A, Jackson-Sillah D, et al. (2007) Using ELISPOT to expose false positive skin test conversion in tuberculosis contacts. PLoS ONE 2: e183. doi:10.1371/journal.pone.0000183
11. Corbett EL, Kathryn C, Millington KA, Ewer K, Cheung YY, et al. (2006) Tuberculosis infection in African nursing students: Tuberculin skin test compared to ELISPOT conversion rates. Int J Tuberc Lung Dis 10: S231.
12. Pai M, Kalantri S, Dheda K (2006) New tools and emerging technologies for the diagnosis of tuberculosis: Part I. Latent tuberculosis. Expert Rev Mol Diagn 6: 413-422.
13. Andersen P, Doherty TM, Pai M, Weldingh K (2007) The prognosis of latent tuberculosis: Can disease be predicted? Trends Mol Med 13: 175-182.
14. American Thoracic Society (2000) Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 161: S221-S247.
15. Doherty TM, Demissie A, Olobo J, Wolday D, Britton S, et al. (2002) Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol 40: 704-706.